Plain-English translation of NCT07109817 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Breast Cancer research guide โPhase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether desloratadine, a medication commonly used for allergies, might prevent or reduce nerve damage in the hands and feet that sometimes happens during breast cancer chemotherapy. Nerve damage from chemotherapy can cause numbness, tingling, and pain that may last long after treatment ends. This study wants to see if taking this medication during your chemotherapy can help protect your nerves.
Nerve damage from chemotherapy is one of the most common side effects that breast cancer patients experience, but currently there are no proven ways to prevent it. Research in animals has shown that this medication might reduce the inflammation in nerves that causes this damage, so doctors want to test whether it works in people.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would receive your planned chemotherapy over 12 weeks, and you would be randomly assigned to either take the medication being tested or a placebo pill alongside your chemotherapy. Throughout the study, you would complete questionnaires about any nerve-related symptoms you experience and provide blood samples so researchers can look for signs of inflammation. The study also tracks your quality of life and any side effects you have during and after treatment.
AI-generated summary from trial data ยท Jun 12, 2026 ยท Not medical advice
United States